EVEREST ORGANICS
Back to Balance Sheet
|
EVEREST ORGANICS Last 5 Year Net Current Assets History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Current Assets (Including Current Investments) | ₹7.98 Cr | ₹-11 Cr | ₹-5.10 Cr | ₹5.32 Cr | ₹12 Cr |
What is the latest Net Current Assets ratio of EVEREST ORGANICS ?
| Year | Net Current Assets |
|---|---|
| Mar2025 | ₹7.98 Cr |
| Mar2024 | ₹-11 Cr |
| Mar2023 | ₹-5.10 Cr |
| Mar2022 | ₹5.32 Cr |
| Mar2021 | ₹12 Cr |
How is Net Current Assets of EVEREST ORGANICS Trending?
| Years | Net Current Assets | % Change | |
|---|---|---|---|
| Mar2025 | ₹7.98 Cr | Positive | |
| Mar2024 | ₹-11 Cr | Negative | |
| Mar2023 | ₹-5.10 Cr | Negative | |
| Mar2022 | ₹5.32 Cr | -55.29 | |
| Mar2021 | ₹12 Cr | - | |
Compare Net Current Assets of peers of EVEREST ORGANICS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| EVEREST ORGANICS | ₹363.7 Cr | 1.8% | -7.3% | 38.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹423,195.0 Cr | 3% | 9.5% | 3.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹169,849.0 Cr | 1.7% | 3.1% | 5.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹149,586.0 Cr | 4.7% | 11.7% | 41.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹109,054.0 Cr | 2.1% | 6.7% | 11.6% | Stock Analytics | |
| CIPLA | ₹108,703.0 Cr | 1.3% | 1.3% | -9.4% | Stock Analytics | |
EVEREST ORGANICS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| EVEREST ORGANICS | 1.8% |
-7.3% |
38.4% |
| SENSEX | -1.7% |
0.5% |
8.3% |
You may also like the below Video Courses